Consort Medical agrees to 505 million pound buyout by Sweden's Recipharm

Text size Aa Aa

(Reuters) – Consort Medical Plc <CSRT.L> on Monday said Sweden’s Recipharm AB <RECIb.ST> would buy the London-listed healthcare company for 1,010 pence per share in cash.

Consort said the offer represented a premium of 39.1% to Friday’s close of 726 pence, valuing the company at about 505 million pounds ($646.20 million) on a fully diluted basis.

(Reporting by Pushkala Aripaka in Bengaluru; Editing by Subhranshu Sahu)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on for a limited time.
Euronews is no longer accessible on Internet Explorer. This browser is not updated by Microsoft and does not support the last technical evolutions. We encourage you to use another browser, such as Edge, Safari, Google Chrome or Mozilla Firefox.